microsatellite stable
Showing 1 - 5 of 5
CCR5, Microsatellite Stable, Metastatic Trial (700mg leronlimab weekly dose, 80mg Regorafenib at week 1, 120mg Regorafenib at
Withdrawn
- CCR5
- +3 more
- 700mg leronlimab weekly dose
- +3 more
- (no location specified)
Feb 15, 2023
Advanced or Metastatic Solid Tumors, Microsatellite Instability Low, Microsatellite Instability High Trial in United States
Recruiting
- Advanced or Metastatic Solid Tumors
- +11 more
-
Tucson, Arizona
- +11 more
Dec 2, 2022
Colorectal Cancer Metastatic, High Immune Infiltrate, Microsatellite Stable Trial in France (Capecitabine, Oxaliplatin,
Recruiting
- Colorectal Cancer Metastatic
- +2 more
- Capecitabine
- +3 more
-
Abbeville, France
- +87 more
Mar 23, 2022
Mismatch Repair-proficient, Colorectal Cancer Metastatic, Microsatellite Stable Trial in Hangzhou (Tislelizumab, Irinotecan,
Recruiting
- Mismatch Repair-proficient
- +2 more
- Tislelizumab
- +2 more
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Dec 17, 2021
Advanced Microsatellite Stable Colorectal Carcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma, Microsatellite
Recruiting
- Advanced Microsatellite Stable Colorectal Carcinoma
- +5 more
- Niraparib
- Panitumumab
-
Atlanta, Georgia
- +2 more
Oct 29, 2021